-+ 0.00%
-+ 0.00%
-+ 0.00%
Gilead and Kite Present Blood Cancer Therapy Data at ASH Annual Meeting
Share
Listen to the news
Gilead and Kite Present Blood Cancer Therapy Data at ASH Annual Meeting
  • Gilead Sciences and Kite will attend the 68th American Society of Hematology Annual Meeting and Exposition on December 12-15, 2026.
  • The program includes 23 presentations from the companies, including seven oral presentations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611040915BIZWIRE_USPR_____20261104_BW303376) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending